Author:
Giagounidis Aristoteles,Fenaux Pierre,Mufti Ghulam J.,Muus Petra,Platzbecker Uwe,Sanz Guillermo,Cripe Larry,Von Lilienfeld-Toal Marie,Wells Richard A.
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference20 articles.
1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Myelodysplastic syndromes. V.2.2008. Available from: http://www.nccn.org/professionals/physician_gls/PDF/mds.pdf . Accessed 4 December 2007
2. Hamblin TJ (2002) Epidemiology of the myelodysplastic syndromes. In: Bennett JM (ed) The myelodysplastic syndromes: pathobiology and clinical management. Marcel Dekker, New York, NY
3. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079–2088
4. Olney HJ, Le Beau MM (2007) Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes. Leuk Res 31:427–434
5. Haase D, Germing U, Schanz J, Pfeilstocker M, Nosslinger T, Hildebrandt B et al (2007) New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2,124 patients. Blood 110:4385–4395
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献